pc 버전으로 이동 중 [시장보고서]세계의 유전자 독성 검사 시장 규모, 점유율 및 성장 분석 : 제품별, 용도별 - 산업 예측(2024-2031년)
세계의 유전자 독성 검사 시장 규모, 점유율 및 성장 분석 : 제품별, 용도별 - 산업 예측(2024-2031년)
Global Genetic Toxicology Testing Market Size, Share, Growth Analysis, By Product(Reagents & Consumables, Assays), By Application(Pharmaceutical & Biotechnology, Food Industry) - Industry Forecast 2024-2031
상품코드 : 1452818
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2024년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ₩ 7,315,000
PDF & Excel (Single User License)
US $ 6,200 ₩ 8,557,000
PDF & Excel (Multiple User License)
US $ 7,100 ₩ 9,799,000
PDF & Excel (Enterprise License)


세계 유전자 독성 검사 시장 규모는 2022년 13억 1,000만 달러로 평가되었습니다. 2023년 14억 8,000만 달러에서 2031년까지 38억 4,000만 달러에 달하고, 예측 기간(2024-2031년) 동안 12.70%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다./p>

유전자 독성 검사는 제약, 생명공학 및 화학 산업에서 중요한 역할을 하고 있으며, 신약, 화학물질 및 소비자 제품의 안전성 평가의 기본 요소로 자리 잡고 있습니다. 이 단계는 인간의 건강과 환경 모두에 대한 잠재적 위험을 철저히 평가할 수 있도록 보장합니다. 규제 당국의 감시 강화, 검사 방법의 발전, 공중 보건 및 안전에 대한 관심 증가로 인해 시장의 중요성이 증가하고 있습니다. 제약 및 화학 분야의 R&D 활동 확대, 세계 보건 및 위생 규제 강화, 유전독성 물질 노출로 인한 장기적 영향 가능성에 대한 인식이 높아짐에 따라 시장 성장에 대한 기대감이 높아지고 있습니다. 전통적인 검사는 여전히 필수적이지만, in vitro 소핵 분석, in silico 모델링, 하이스루풋 스크리닝과 같은 혁신적인 기술이 이를 보완하여 보다 신속하고 정확하며 비용 효율적인 검사를 가능하게 하고 있습니다. 또한, 동물 사용을 최소화하기 위한 대체 검사법으로의 전환은 윤리적 고려 사항과 규제 요건에 부합하여 비동물 검사 모델의 채택을 촉진하고 있습니다. 유전자 독성 검사 전문 개발 위탁기관 등 시장의 주요 업체들은 다양한 검사 서비스를 제공함으로써 시장의 역동적인 상황에 기여하고 있습니다.


주요 요약

조사 방법

상위 시장 분석

주요 시장 인사이트

시장 역학과 전망

세계의 유전자 독성 검사 시장 : 제품별

세계의 유전자 독성 검사 시장 : 용도별

세계의 유전자 독성 검사 시장 규모 : 지역별

경쟁 구도

주요 기업 개요

LSH 24.04.12
영문 목차


Global Genetic Toxicology Testing Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.84 billion by 2031, growing at a CAGR of 12.70% during the forecast period (2024-2031).

Genetic toxicology testing plays a crucial role in the pharmaceutical, biotechnology, and chemical industries, serving as a fundamental component in the safety assessment of new drugs, chemicals, and consumer products. This phase ensures a thorough evaluation of potential risks to both human health and the environment. The market's significance is on the rise due to heightened regulatory scrutiny, advancements in testing methodologies, and an increased focus on public health and safety. Factors driving its notable growth include expanding research and development activities in pharmaceutical and chemical sectors, stringent global health regulations, and a growing awareness of the potential long-term impacts of exposure to genotoxic substances. While traditional tests remain essential, innovative techniques such as in vitro micronucleus assays, in silico modeling, and high-throughput screening methods are complementing them, facilitating faster, more accurate, and cost-effective testing. Additionally, the shift towards alternative testing methods to minimize animal usage aligns with ethical considerations and regulatory requirements, fostering the adoption of non-animal testing models. Key players in the market, including contract research organizations specializing in genetic toxicology testing, contribute to its dynamic landscape by offering a diverse range of testing services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Toxicology Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genetic Toxicology Testing Market Segmental Analysis

The global genetic toxicology testing market is segmented on the basis of Type, Product, Application and region. By Type, the market is segmented into In Vitro, In Vivo. By Product, the market is segmented into Reagents & Consumables, Assays, Services. By Application, the market is segmented into Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry, Other. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Genetic Toxicology Testing Market

The increasing recognition among individuals and healthcare professionals regarding the significance of genetic health and its consequences serves as a major catalyst. Genetic toxicology testing plays a crucial role in pinpointing potential hazards linked to exposure to diverse environmental elements like chemicals, medications, and pollutants. This, in turn, contributes to personalized healthcare and facilitates the implementation of preventive measures.

Restraints in the Global Genetic Toxicology Testing Market

Genetic toxicology testing delves into scrutinizing an individual's genetic data, giving rise to ethical considerations regarding privacy, consent, and the potential for data misuse. The meticulous management of genetic information, encompassing its collection, storage, and utilization, necessitates adherence to stringent privacy regulations. This cautious approach may pose a challenge to the broad acceptance and integration of genetic testing practices.

Market Trends of the Global Genetic Toxicology Testing Market

The market is undergoing a notable transition towards in vitro genetic toxicology testing techniques, supplanting traditional animal-based methods with cell-based assays. This shift is fueled by the benefits these assays provide, including diminished ethical concerns, quicker results, cost-effectiveness, and enhanced relevance to human biology. In vitro approaches like the Ames test, micronucleus assay, and Comet assay are increasingly popular for their capacity to furnish precise data on the genotoxicity and mutagenicity potential of substances. Regulatory bodies are actively endorsing the adoption of in vitro methods, amplifying their incorporation into the industry.

Table of Contents

Executive Summary

Research Methodology

Parent Market Analysis

Key Market Insights

Market Dynamics & Outlook

Global Genetic Toxicology Testing Market by Product

Global Genetic Toxicology Testing Market by Application

Global Genetic Toxicology Testing Market Size by Region

Competitive Landscape

Key Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기